Prioritizing Candidate Genetic Modifiers of BRCA1 and BRCA2 Using a Combinatorial Analysis of Global Expression and Polymorphism
Epidemiological evidence from different studies has shown that genes harboring sequence variations may modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Current attempts to identify genetic modifiers of BRCA1 and BRCA2 associated risk have focused on a candidate gene-based approach or the development of large genome-wide association studies. However, both methods have notable limitations. This chapter describes a novel approach for analyzing gene expression differences to prioritize candidate modifier genes for single nucleotide polymorphism association studies. The advantage that gives this strategy an edge over other candidate gene-based studies is its potential to identify candidate genes that interact with exogenous risk factors to cause or modify cancer, without detailed a priori knowledge of the molecular pathways involved.
- Compartmentalized Protein Kinase C Activation in Ovarian Carcinoma Cells
- Integrating Molecular Biomarkers into Current Clinical Management in Melanoma
- Identification and Analysis of Precursors to Invasive Pancreatic Cancer
- The Oncofetal Protein p65 in Breast Cancer Detection
- PPAR/ Agonist Increases the Expression of PGE2 Receptor Subtype EP4 in Human Lung Carcinoma Cells
- 17 Direct Sequencing for Peutz-Jeghers Gene LKB1 (STK11) Mutations
- Detection of Telomerase hTERT Gene Expression and Its Splice Variants by RT-PCR
- YKL-40: A Novel Marker Shared by Chronic Inflammation and Oncogenic Transformation
- Molecular Diagnosis of the 5q Deletion in Malignant Myeloid Disorders
- Immunohistochemical Analysis of 8-Nitroguanine, A Nitrative DNA Lesion, in Relation to Inflammation-Associated Carcinogenesis